Resource Center
Explore Resource Types
We have housed the technical documents (SDS, COAs, Manuals and more) in a dedicated section.
Explore all All Resources
Filters
Select resource types
Select products & services
Select solutions (2)
Active Filters (2)
Clear All
1 - 12 of 179 Results
Sort by:
Best Match
Product Note
Protocol/SOP
IVISbrite lentiviral particles transduction protocol (SOP)
Transduction protocol for using Revvity's IVISbrite lentiviral particles.
Article
cst-research-spotlight-qa-alves-opioids-bone-homogenization
Method development for toxicological analysis of synthetic opioids from bone.
Brochure
Drug discovery and development tailor made
Learn more about our Custom Discovery Reagent and Assay Services to further your research, backed by 30+ years of experience.
Flyer
Radiochemical Custom Synthesis and Labeling
Radiochemical custom synthesis and labeling services from Revvity
Case Study
Assessment of MYC-driven progression of small cell lung cancer
Researchers at Huntsman Cancer Center use GEMM and the Quantum microCT system for evaluating small cell lung cancer.
Flyer
The T-SPOT.CMV test assesses a patient’s level of anti-CMV cell-mediated immunity
Explore how Cytomegalovirus (CMV) cell-mediated immunity and the T-SPOT.CMV test can enhance understanding of CMV immune status, crucial for managing patients at risk of disease after organ and stem cell transplants.
Whitepaper
How CRISPR-based functional genomics is transforming drug discovery
Exploring how functional genomics is used in preclinical drug discovery with target identification, drug response mechanisms, and in vivo tumor biology.
Application Note
Profiling compound effect on immune cells by combining ImmuSignature assays and LEGENDplex bead-based multiplex protein quantification
Explore Revvity's preclinical services for cell engineering and screening in our ebook.
Application Note
Effectiveness of CRISPR-Cas9 using pools of Dharmacon™ Edit-R™ synthetic crRNAs in high-content analysis screening experiments
Find out about the effectiveness of CRISPR-Cas9 using pools of Dharmacon™ Edit-R™ synthetic crRNAs in HCA screening experiments.
Application Note
Pooled phenotypic CRISPR screening enables the identification of synergistic drug combinations for cancer therapy
This application note demonstrates how a pooled phenotypic CRISPR screening can be used to identify synergistic drug combinations for cancer therapy
Literature - Publication Review
Linking genes to phenotypes with CRISPR screening
Literature review on the multiple CRIPSR screening techniques available for drug discovery and their benefits.
Looking for technical documents?
Find the technical documents you need, ASAP, in our easy-to-search library.